NEVROLOGIK MUAMMOLAR VA COVID-19 O'RTASIDAGI BOG'LIQLIKNI ERTA RETROSPEKTIV TAHLIL QILISH NATIJALARI
##article.subject##:
COVID-19 nevrologik belgilari va asoratlari, kavernoz sinus trombozi, komorbidliklar, retrospektiv tahlil##article.abstract##
COVID-19 kontekstida nevrologik ta'sirlarni oydinlashtirish maqsadida 2020 va 2022-yillarda Toshkent shahridagi ko‘p tarmoqli tibbiyot markazida koronavirus infeksiyasi bilan kasallangan bemorlar orasida kuzatilgan nevrologik belgilarn o‘rganilib, umumlashtirildi. COVID-19 ning nevrologik alomatlarining xilma-xilligi kasallikning ko‘p qirraliligini va bemorlarning umumiy salomatligiga ta'sirini ta'kidlaydi. Shuningdek, ushbu nevrologik asoratlarning tibbiyot tizimlariga soladigan katta yuklari, maxsus davolash va kuzatuv yondashuvlarini joriy etish zarurligini ko‘rsatdi. Shuning uchun, bu alomatlar bilan bog‘liq nogironlik va o‘limni kamaytirish uchun to‘g‘ri va malakali patogenetik davolashni o‘z vaqtida aniqlash va amalga oshirish muhimdir.
Библиографические ссылки
N. Zhu, D. Zhang, W. Wang, et al., A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med. 382 (2020) 727–733.
World Health Organization Coronavirus Disease (COVID-19), Situation Report- 117, Accessed May 16, 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200516- covid-19-sitrep-117.
A.J. Rodriguez-Morales, J.A. Cardona-Ospina, E. Gutiйrrez-Ocampo, et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Travel Med. Infect. Dis. (2020) 101623.
N. Chen, M. Zhou, X. Dong, et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet 395 (2020) 507–513.
Z. Wu, McGoogan JM, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention, JAMA (2020) 1–4.
L. Mao, H. Jin, M. Wang, et al., Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019in Wuhan,China, JAMA Neurol. (2020)1-5.
J. Helms, S. Kremer, H. Merdji, et al., Neurologic features in severe SARS-CoV-2 infection, N. Engl. J. Med. (2020) 1–7.
C.W. Yancy, COVID-19 and African Americans, JAMA (2020) 1–3.
Novel Coronavirus pneumonia diagnosis and treatment plan (Provisional 7th Edition), Accessed April 30, 2020 https://www.chinalawtranslate.com/en/ coronavirus-treatment-plan-7/.
P.Pinna1, P.Grewal1, et all. Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline. Journal of the Neurological Sciences 415 (2020) 116969
L.Q. Li, T. Huang, Y.Q. Wang, et al., COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis, J. Med. Virol. (2020) 1–6.
N. Poyiadji, G. Shahin, D. Noujaim, M. Stone, S. Patel, B. Griffith, COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI features, Radiology (2020) 201187.
A. Virani, E. Rabold, T. Hanson, et al., Guillain-Barrй Syndrome associated with SARS-CoV-2 infection, IDCases (2020) e00771.
C. Gutirrez-Ortiz, A. Mndez, S. Rodrigo-Rey, et al., Miller Fisher Syndrome and polyneuritis cranialis in COVID-19, Neurology (2020) 1–2.
A.M. Baig, A. Khaleeq, U. Ali, H. Syeda, Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms, ACS Chem. Neurosci. 11 (2020) 995–998.
A.M. Baig, Neurological manifestations in COVID-19 caused by SARS-CoV-2, CNS Neurosci. Ther. 26 (2020) 499–501.
K. Bohmwald, Gбlvez NMS, M. Rнos, A.M. Kalergis, Neurologic alterations due to Respiratory Virus Infections, Front. Cell. Neurosci. 12 (2018) 386
